Death of effector memory T cells characterizes AIDS

Frontiers in Bioscience

Volumn 14, Issue 11, 2009, Pages 4386-4400

  Mireille, Laforge ^b   Anna, Senik ^b   Marie Christine, Cumont ^a   Valerie, Monceaux ^a   Bruno, Hurtrel ^a   Jerome, Estaquier ^a,b,c  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

AIDS; Apoptosis; Bim; Cathepsin; Depletion; Fas; HIV; Lysosome; Mitochondria; Review

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

CHEMOKINE RECEPTOR CCR5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; CD4+ T LYMPHOCYTE; CYTOLOGY; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MITOCHONDRION; PERMEABILITY; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOLOGIC MEMORY; MITOCHONDRIA; PERMEABILITY; RECEPTORS, CCR5;

EID: 63849176054     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3535     Document Type: Article

References (177)

1. M. D. Jacobson, M. Weil and M. C. Raff: Programmed cell death in animal development. Cell 88, 347-354. (1997) (Pubitemid 27131376)
2. J. F. Kerr, A. H. Wyllie and A. R. Currie: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-257. (1972)
3. S. J. Martin, C. P. Reutelingsperger, A. J. McGahon, J. A. Rader, R. C. van Schie, D. M. LaFace and D. R. Green: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182, 1545-1556(1995)
4. A. H. Wyllie, J. F. Kerr and A. R. Currie: Cell death: the significance of apoptosis. Int Rev Cytol 68, 251-306(1980) (Pubitemid 11219226)
5. A. Gross, J. M. McDonnell and S. J. Korsmeyer: BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13, 1899-1911(1999) (Pubitemid 29407357)
6. J. Yang, X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T. I. Peng, D. P. Jones and X. Wang: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked [see comments]. Science 275, 1129-1132(1997) (Pubitemid 27097312)
7. R. M. Kluck, E. Bossy-Wetzel, D. R. Green and D. D. Newmeyer: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis [see comments]. Science 275, 1132-1136(1997) (Pubitemid 27097313)
8. J. C. Martinou and D. R. Green: Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2, 63-67. (2001) (Pubitemid 33676963)
9. J. C. Ameisen, J. Estaquier and T. Idziorek: From AIDS to parasite infection: pathogen-mediated subversion of programmed cell death as a mechanism for immune dysregulation. Immunol Rev 142, 9-51(1994)
10. G. Kroemer and J. C. Reed: Mitochondrial control of cell death. Nat Med 6, 513-519. (2000) (Pubitemid 30305900)
11. C. B. Thompson: Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462. (1995)
12. D. D. Ho, A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard and M. Markowitz: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection [see comments]. Nature 373, 123-126(1995)
13. M. Clerici, N. I. Stocks, R. A. Zajac, R. N. Boswell, D. R. Lucey, C. S. Via and G. M. Shearer: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 84, 1892-1899. (1989) (Pubitemid 20016195)
14. L. Meyaard, S. A. Otto, R. R. Jonker, M. J. Mijnster, R. P. Keet and F. Miedema: Programmed death of T cells in HIV-1 infection. Science 257, 217-219(1992)
15. A. Sarin, M. Clerici, S. P. Blatt, C. W. Hendrix, G. M. Shearer and P. A. Henkart: Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors. J Immunol 153, 862-872. (1994) (Pubitemid 24206317)
16. M. L. Gougeon, S. Garcia, J. Heeney, R. Tschopp, H. Lecoeur, D. Guetard, V. Rame, C. Dauguet and L. Montagnier: Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses 9, 553-563(1993) (Pubitemid 23207427)
17. N. Oyaizu, T. W. McCloskey, M. Coronesi, N. Chirmule, V. S. Kalyanaraman and S. Pahwa: Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82, 3392-3400(1993) (Pubitemid 23356712)
18. M. Clerici, A. Sarin, R. L. Coffman, T. A. Wynn, S. P. Blatt, C. W. Hendrix, S. F. Wolf, G. M. Shearer and P. A. Henkart: Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci U S A 91, 11811-11815(1994) (Pubitemid 24368553)
19. J. Estaquier, T. Idziorek, F. de Bels, F. Barre-Sinoussi, B. Hurtrel, A. M. Aubertin, A. Venet, M. Mehtali, E. Muchmore, P. Michel and et al.: Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A 91, 9431-9435(1994) (Pubitemid 24297928)
20. D. E. Lewis, D. S. Tang, A. Adu-Oppong, W. Schober and J. R. Rodgers: Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol 153, 412-420(1994) (Pubitemid 24186555)
21. C. A. Muro-Cacho, G. Pantaleo and A. S. Fauci: Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 154, 5555-5566(1995)
22. T. H. Finkel, G. Tudor-Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht and A. Kupfer: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes [see comments]. Nat Med 1, 129-134(1995)
23. E. Prati, R. Gorla, F. Malacarne, P. Airo, D. Brugnoni, F. Gargiulo, A. Tebaldi, F. Castelli, G. Carosi and R. Cattaneo: Study of spontaneous apoptosis in HIV+ patients: correlation with clinical progression and T cell loss. AIDS Res Hum Retroviruses 13, 1501-1508(1997) (Pubitemid 27500579)
24. T. J. Liegler, W. Yonemoto, T. Elbeik, E. Vittinghoff, S. P. Buchbinder and W. C. Greene: Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors. J Infect Dis 178, 669-679(1998) (Pubitemid 28397213)
25. S. J. Chavan, S. L. Tamma, M. Kaplan, M. Gersten and S. G. Pahwa: Reduction in T cell apoptosis in patients with HIV disease following antiretroviral therapy. Clin Immunol 93, 24-33(1999) (Pubitemid 29459959)
26. S. P. Aries, K. Weyrich, B. Schaaf, F. Hansen, R. H. Dennin and K. Dalhoff: Early T-cell apoptosis and Fas expression during antiretroviral therapy in individuals infected with human immunodeficiency virus-1. Scand J Immunol 48, 86-91(1998) (Pubitemid 28329157)
27. A. D. Badley, D. H. Dockrell, A. Algeciras, S. Ziesmer, A. Landay, M. M. Lederman, E. Connick, H. Kessler, D. Kuritzkes, D. H. Lynch, P. Roche, H. Yagita and C. V. Paya: In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest 102, 79-87. (1998) (Pubitemid 28323833)
28. T. Bohler, J. Walcher, G. Holzl-Wenig, M. Geiss, B. Buchholz, R. Linde and K. M. Debatin: Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents. Aids 13, 779-789(1999) (Pubitemid 29224579)
29. A. D. Badley, A. A. Pilon, A. Landay and D. H. Lynch: Mechanisms of HIV-associated lymphocyte apoptosis. Blood 96, 2951-2964. (2000)
30. O. Benveniste, A. Flahault, F. Rollot, C. Elbim, J. Estaquier, B. Pedron, X. Duval, N. Dereuddre-Bosquet, P. Clayette, G. Sterkers, A. Simon, J. C. Ameisen and C. Leport: Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads. J Infect Dis 191, 1670-1679(2005) (Pubitemid 40656755)
31. B. H. Hahn, G. M. Shaw, K. M. De Cock and P. M. Sharp: AIDS as a zoonosis: scientific and public health implications. Science 287, 607-614(2000) (Pubitemid 30070900)
32. S. R. Broussard, S. I. Staprans, R. White, E. M. Whitehead, M. B. Feinberg and J. S. Allan: Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J Virol 75, 2262-2275(2001) (Pubitemid 32147565)
33. G. Silvestri, D. L. Sodora, R. A. Koup, M. Paiardini, S. P. O'Neil, H. M. McClure, S. I. Staprans and M. B. Feinberg: Nonpathogenic SIV Infection of Sooty Mangabeys Is Characterized by Limited Bystander Immunopathology Despite Chronic High-Level Viremia. Immunity 18, 441-452(2003) (Pubitemid 36351522)
34. M. A. Rey-Cuille, J. L. Berthier, M. C. Bomsel-Demontoy, Y. Chaduc, L. Montagnier, A. G. Hovanessian and L. A. Chakrabarti: Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol 72, 3872-3886(1998) (Pubitemid 28188688)
35. O. M. Diop, A. Gueye, M. Dias-Tavares, C. Kornfeld, A. Faye, P. Ave, M. Huerre, S. Corbet, F. Barre-Sinoussi and M. C. Muller-Trutwin: High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J Virol 74, 7538-7547(2000) (Pubitemid 30613099)
36. R. Onanga, C. Kornfeld, I. Pandrea, J. Estaquier, S. Souquiere, P. Rouquet, V. P. Mavoungou, O. Bourry, S. M'Boup, F. Barre-Sinoussi, F. Simon, C. Apetrei, P. Roques and M. C. Muller-Trutwin: High levels of viral replication contrast with only transient changes in CD4 (+) and CD8 (+) cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx. J Virol 76, 10256-10263(2002)
37. I. C. Davis, M. Girard and P. N. Fultz: Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis. J Virol 72, 4623-4632. (1998) (Pubitemid 28215636)
38. A. M. Del Llano, J. P. Amieiro-Puig, E. N. Kraiselburd, M. J. Kessler, C. A. Malaga and J. A. Lavergne: The combined assessment of cellular apoptosis, mitochondrial function and proliferative response to pokeweed mitogen has prognostic value in SIV infection. J Med Primatol 22, 147-153(1993)
39. H. Schuitemaker, L. Meyaard, N. A. Kootstra, R. Dubbes, S. A. Otto, M. Tersmette, J. L. Heeney and F. Miedema: Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J Infect Dis 168, 1140-1147. (1993) (Pubitemid 23317127)
40. F. J. Novembre, J. de Rosayro, S. Nidtha, S. P. O'Neil, T. R. Gibson, T. Evans-Strickfaden, C. E. Hart and H. M. McClure: Rapid CD4 (+) T-cell loss induced by human immunodeficiency virus type 1 (NC) in uninfected and previously infected chimpanzees. J Virol 75, 1533-1539(2001) (Pubitemid 32094710)
41. S. J. Little, A. R. McLean, C. A. Spina, D. D. Richman and D. V. Havlir: Viral dynamics of acute HIV-1 infection. J Exp Med 190, 841-850(1999) (Pubitemid 29451629)
42. H. Soudeyns and G. Pantaleo: The moving target: mechanisms of HIV persistence during primary infection. Immunol Today 20, 446-450(1999) (Pubitemid 29476073)
43. M. P. D'Souza and B. J. Mathieson: Early phases of HIV type 1 infection. AIDS Res Hum Retroviruses 12, 1-9(1996) (Pubitemid 26011155)
44. K. A. Reimann, K. Tenner-Racz, P. Racz, D. C. Montefiori, Y. Yasutomi, W. Lin, B. J. Ransil and N. L. Letvin: Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 68, 2362-2370(1994) (Pubitemid 24091915)
45. L. Chakrabarti, P. Isola, M. C. Cumont, M. A. Claessens-Maire, M. Hurtrel, L. Montagnier and B. Hurtrel: Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells. Am J Pathol 144, 1226-1237(1994) (Pubitemid 24172085)
46. J. W. Mellors, L. A. Kingsley, C. R. Rinaldo, Jr., J. A. Todd, B. S. Hoo, R. P. Kokka and P. Gupta: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 122, 573-579(1995)
47. A. Watson, J. Ranchalis, B. Travis, J. McClure, W. Sutton, P. R. Johnson, S. L. Hu and N. L. Haigwood: Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J Virol 71, 284-290(1997) (Pubitemid 26412290)
48. J. D. Lifson, M. A. Nowak, S. Goldstein, J. L. Rossio, A. Kinter, G. Vasquez, T. A. Wiltrout, C. Brown, D. Schneider, L. Wahl, A. L. Lloyd, J. Williams, W. R. Elkins, A. S. Fauci and V. M. Hirsch: The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol 71, 9508-9514(1997) (Pubitemid 27492396)
49. S. I. Staprans, P. J. Dailey, A. Rosenthal, C. Horton, R. M. Grant, N. Lerche and M. B. Feinberg: Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection. J Virol 73, 4829-4839(1999) (Pubitemid 29246743)
50. I. Pandrea, C. Apetrei, J. Dufour, N. Dillon, J. Barbercheck, M. Metzger, B. Jacquelin, R. Bohm, P. A. Marx, F. Barre-Sinoussi, V. M. Hirsch, M. C. Muller-Trutwin, A. A. Lackner and R. S. Veazey: Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts. J Virol 80, 4858-4867(2006)
51. C. Kornfeld, M. J. Ploquin, I. Pandrea, A. Faye, R. Onanga, C. Apetrei, V. Poaty-Mavoungou, P. Rouquet, J. Estaquier, L. Mortara, J. F. Desoutter, C. Butor, R. Le Grand, P. Roques, F. Simon, F. Barre-Sinoussi, O. M. Diop and M. C. Muller-Trutwin: Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 115, 1082-1091(2005) (Pubitemid 40489413)
52. J. Estaquier, V. Monceaux, M. C. Cumont, A. M. Aubertin, B. Hurtrel and J. C. Ameisen: Early changes in peripheral blood T cells during primary infection of rhesus macaques with a pathogenic SIV. J Med Primatol 29, 127-135(2000)
53. T. Iida, H. Ichimura, M. Ui, T. Shimada, W. Akahata, T. Igarashi, T. Kuwata, E. Ido, S. Yonehara, J. Imanishi and M. Hayami: Sequential analysis of apoptosis induction in peripheral blood mononuclear cells and lymph nodes in the early phase of pathogenic and nonpathogenic SIVmac infection. AIDS Res Hum Retroviruses 15, 721-729(1999) (Pubitemid 29237395)
54. J. J. Wykrzykowska, M. Rosenzweig, R. S. Veazey, M. A. Simon, K. Halvorsen, R. C. Desrosiers, R. P. Johnson and A. A. Lackner: Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J Exp Med 187, 1767-1778(1998)
55. V. Monceaux, J. Estaquier, M. Fevrier, M. C. Cumont, Y. Riviere, A. M. Aubertin, J. C. Ameisen and B. Hurtrel: Extensive apoptosis in lymphoid organs during primary SIV infection predicts rapid progression towards AIDS. Aids 17, 1585-1596(2003) (Pubitemid 36951679)
56. Q. Li, L. Duan, J. D. Estes, Z. M. Ma, T. Rourke, Y. Wang, C. Reilly, J. Carlis, C. J. Miller and A. T. Haase: Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434, 1148-1152(2005) (Pubitemid 40663495)
57. K. A. Reimann, R. A. Parker, M. S. Seaman, K. Beaudry, M. Beddall, L. Peterson, K. C. Williams, R. S. Veazey, D. C. Montefiori, J. R. Mascola, G. J. Nabel and N. L. Letvin: Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. J Virol 79, 8878-8885(2005) (Pubitemid 40934798)
58. B. Ling, R. S. Veazey, A. Luckay, C. Penedo, K. Xu, J. D. Lifson and P. A. Marx: SIV (mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. Aids 16, 1489-1496(2002) (Pubitemid 34804213)
59. M. C. Cumont, O. Diop, B. Vaslin, C. Elbim, L. Viollet, V. Monceaux, S. Lay, G. Silvestri, R. Le Grand, M. Muller-Trutwin, B. Hurtrel and J. Estaquier: Early divergence in lymphoid tissue apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J Virol 82, 1175-1184(2008)
60. I. Pandrea, R. M. Ribeiro, R. Gautam, T. Gaufin, M. Pattison, M. Barnes, C. Monjure, C. Stoulig, J. Dufour, W. Cyprian, G. Silvestri, M. D. Miller, A. S. Perelson and C. Apetrei: Simian immunodeficiency virus SIVagm dynamics in African green monkeys. J Virol 82, 3713-3724(2008) (Pubitemid 351429947)
61. I. V. Pandrea, R. Gautam, R. M. Ribeiro, J. M. Brenchley, I. F. Butler, M. Pattison, T. Rasmussen, P. A. Marx, G. Silvestri, A. A. Lackner, A. S. Perelson, D. C. Douek, R. S. Veazey and C. Apetrei: Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J Immunol 179, 3035-3046(2007)
62. L. Viollet, V. Monceaux, F. Petit, R. Ho Tsong Fang, M. C. Cumont, B. Hurtrel and J. Estaquier: Death of CD4+ T cells from lymph nodes during primary SIVmac251 infection predicts the rate of AIDS progression. J Immunol 177, 6685-6694(2006) (Pubitemid 44715032)
63. V. Monceaux, L. Viollet, F. Petit, M. C. Cumont, G. R. Kaufmann, A. M. Aubertin, B. Hurtrel, G. Silvestri and J. Estaquier: CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques. J Virol 81, 13865-13875(2007) (Pubitemid 350247880)
64. A. Harari, S. Petitpierre, F. Vallelian and G. Pantaleo: Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103, 966-972(2004) (Pubitemid 38129558)
65. E. S. Rosenberg, J. M. Billingsley, A. M. Caliendo, S. L. Boswell, P. E. Sax, S. A. Kalams and B. D. Walker: Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278, 1447-1450(1997) (Pubitemid 27509814)
66. E. S. Rosenberg, M. Altfeld, S. H. Poon, M. N. Phillips, B. M. Wilkes, R. L. Eldridge, G. K. Robbins, R. T. D'Aquila, P. J. Goulder and B. D. Walker: Immune control of HIV-1 after early treatment of acute infection. Nature 407, 523-526(2000)
67. J. J. Mattapallil, N. L. Letvin and M. Roederer: T-cell dynamics during acute SIV infection. Aids 18, 13-23(2004) (Pubitemid 38402313)
68. J. J. Mattapallil, D. C. Douek, B. Hill, Y. Nishimura, M. Martin and M. Roederer: Massive infection and loss of memory CD4 (+) T cells in multiple tissues during acute SIV infection. Nature (2005)
69. L. J. Picker, S. I. Hagen, R. Lum, E. F. Reed-Inderbitzin, L. M. Daly, A. W. Sylwester, J. M. Walker, D. C. Siess, M. Piatak, Jr.,., C. Wang, D. B. Allison, V. C. Maino, J. D. Lifson, T. Kodama and M. K. Axthelm: Insufficient Production and Tissue Delivery of CD4+ Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection. J Exp Med 200, 1299-1314(2004) (Pubitemid 39552571)
70. R. S. Veazey, K. G. Mansfield, I. C. Tham, A. C. Carville, D. E. Shvetz, A. E. Forand and A. A. Lackner: Dynamics of CCR5 expression by CD4 (+) T cells in lymphoid tissues during simian immunodeficiency virus infection. J Virol 74, 11001-11007. (2000) (Pubitemid 32223965)
71. R. Veazey, B. Ling, I. Pandrea, H. McClure, A. Lackner and P. Marx: Decreased CCR5 expression on CD4+ T cells of SIV-infected sooty mangabeys. AIDS Res Hum Retroviruses 19, 227-233(2003) (Pubitemid 36359888)
72. A. M. de Roda Husman, H. Blaak, M. Brouwer and H. Schuitemaker: CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection. J Immunol 163, 4597-4603. (1999) (Pubitemid 29474531)
73. M. A. Ostrowski, S. J. Justement, A. Catanzaro, C. A. Hallahan, L. A. Ehler, S. B. Mizell, P. N. Kumar, J. A. Mican, T. W. Chun and A. S. Fauci: Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 161, 3195-3201(1998) (Pubitemid 28425749)
74. J. Reynes, P. Portales, M. Segondy, V. Baillat, P. Andre, B. Reant, O. Avinens, G. Couderc, M. Benkirane, J. Clot, J. F. Eliaou and P. Corbeau: CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1. J Infect Dis 181, 927-932. (2000) (Pubitemid 30194475)
75. J. Reynes, P. Portales, M. Segondy, V. Baillat, P. Andre, O. Avinens, M. C. Picot, J. Clot, J. F. Eliaou and P. Corbeau: CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression. Aids 15, 1627-1634(2001) (Pubitemid 32918116)
76. J. J. Zaunders, L. Moutouh-de Parseval, S. Kitada, J. C. Reed, S. Rought, D. Genini, L. Leoni, A. Kelleher, D. A. Cooper, D. E. Smith, P. Grey, J. Estaquier, S. Little, D. D. Richman and J. Corbeil: Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2. J Infect Dis 187, 1735-1747(2003) (Pubitemid 36667884)
77. P. Loetscher, M. Seitz, M. Baggiolini and B. Moser: Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 184, 569-577(1996) (Pubitemid 26324110)
78. V. Monceaux, L. Viollet, F. Petit, R. H. Fang, M. C. Cumont, J. Zaunders, B. Hurtrel and J. Estaquier: CD8+ T cell dynamics during primary simian immunodeficiency virus infection in macaques: relationship of effector cell differentiation with the extent of viral replication. J Immunol 174, 6898-6908(2005) (Pubitemid 40705654)
79. C. Terai, R. S. Kornbluth, C. D. Pauza, D. D. Richman and D. A. Carson: Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 87, 1710-1715(1991)
80. R. T. Gandhi, B. K. Chen, S. E. Straus, J. K. Dale, M. J. Lenardo and D. Baltimore: HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism. J Exp Med 187, 1113-1122(1998) (Pubitemid 28176411)
81. F. Petit, D. Arnoult, J. D. Lelievre, L. Moutouh-de Parseval, A. J. Hance, P. Schneider, J. Corbeil, J. C. Ameisen and J. Estaquier: Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death. J Biol Chem 277, 1477-1487(2002) (Pubitemid 34968903)
82. M. Jaattela, C. Cande and G. Kroemer: Lysosomes and mitochondria in the commitment to apoptosis: a potential role for cathepsin D and AIF. Cell Death Differ 11, 135-136(2004) (Pubitemid 38159636)
83. M. E. Guicciardi, M. Leist and G. J. Gores: Lysosomes in cell death. Oncogene 23, 2881-2890(2004) (Pubitemid 38638850)
84. M. Gyrd-Hansen, T. Farkas, N. Fehrenbacher, L. Bastholm, M. Hoyer-Hansen, F. Elling, D. Wallach, R. Flavell, G. Kroemer, J. Nylandsted and M. Jaattela: Apoptosome-independent activation of the lysosomal cell death pathway by caspase-9. Mol Cell Biol 26, 7880-7891(2006) (Pubitemid 44630989)
85. A. C. Johansson, H. Steen, K. Ollinger and K. Roberg: Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ 10, 1253-1259(2003) (Pubitemid 37407127)
86. N. Bidere, H. K. Lorenzo, S. Carmona, M. Laforge, F. Harper, C. Dumont and A. Senik: Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 278, 31401-31411(2003) (Pubitemid 36994661)
87. M. Laforge, F. Petit, J. Estaquier and A. Senik: Commitment to apoptosis in CD4 (+) T lymphocytes productively infected with human immunodeficiency virus type 1 is initiated by lysosomal membrane permeabilization, itself induced by the isolated expression of the viral protein Nef. J Virol 81, 11426-11440(2007) (Pubitemid 47536113)
88. H. W. Kestler, 3rd, D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel and R. C. Desrosiers: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662(1991)
89. B. L. Wei, V. K. Arora, J. L. Foster, D. L. Sodora and J. V. Garcia: In vivo analysis of Nef function. Curr HIV Res 1, 41-50(2003)
90. N. Michel, K. Ganter, S. Venzke, J. Bitzegeio, O. T. Fackler and O. T. Keppler: The Nef protein of human immunodeficiency virus is a broad-spectrum modulator of chemokine receptor cell surface levels that acts independently of classical motifs for receptor endocytosis and Galphai signaling. Mol Biol Cell 17, 3578-3590(2006) (Pubitemid 44156450)
91. A. Rasola, D. Gramaglia, C. Boccaccio and P. M. Comoglio: Apoptosis enhancement by the HIV-1 Nef protein. J Immunol 166, 81-88(2001) (Pubitemid 32038419)
92. Z. Hanna, D. G. Kay, N. Rebai, A. Guimond, S. Jothy and P. Jolicoeur: Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95, 163-175(1998) (Pubitemid 28473778)
93. S. P. Aries, B. Schaaf, C. Muller, R. H. Dennin and K. Dalhoff: Fas (CD95) expression on CD4+ T cells from HIV-infected patients increases with disease progression. J Mol Med 73, 591-593(1995) (Pubitemid 26015288)
94. C. B. Baumler, T. Bohler, I. Herr, A. Benner, P. H. Krammer and K. M. Debatin: Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 88, 1741-1746(1996) (Pubitemid 26307070)
95. T. Bohler, K. M. Debatin and R. Linde: Sensitivity of CD4+ peripheral blood T cells toward spontaneous and CD95 (APO-1/Fas)-induced apoptosis in pediatric human immunodeficiency virus infection [letter; comment]. Blood 94, 1829-1833(1999) (Pubitemid 29411338)
96. D. H. Dockrell, A. D. Badley, A. Algeciras-Schimnich, M. Simpson, R. Schut, D. H. Lynch and C. V. Paya: Activationinduced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number. AIDS Res Hum Retroviruses 15, 1509-1518(1999)
97. J. Estaquier, T. Idziorek, W. Zou, D. Emilie, C. M. Farber, J. M. Bourez and J. C. Ameisen: T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1) - mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med 182, 1759-1767(1995)
98. J. Estaquier, M. Tanaka, T. Suda, S. Nagata, P. Golstein and J. C. Ameisen: Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virusinfected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood 87, 4959-4966(1996) (Pubitemid 26189837)
99. R. Gehri, S. Hahn, M. Rothen, M. Steuerwald, R. Nuesch and P. Erb: The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells. Aids 10, 9-16(1996) (Pubitemid 26016397)
100. N. Hosaka, N. Oyaizu, M. H. Kaplan, H. Yagita and S. Pahwa: Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons. J Infect Dis 178, 1030-1039(1998) (Pubitemid 28452195)
101. P. D. Katsikis, E. S. Wunderlich, C. A. Smith and L. A. Herzenberg: Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 181, 2029-2036(1995)
102. P. D. Katsikis, M. E. Garcia-Ojeda, E. S. Wunderlich, C. A. Smith, H. Yagita, K. Okumura, N. Kayagaki, M. Alderson and L. A. Herzenberg: Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. Int Immunol 8, 1311-1317. (1996) (Pubitemid 26289910)
103. F. Silvestris, P. Cafforio, M. A. Frassanito, M. Tucci, A. Romito, S. Nagata and F. Dammacco: Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. Aids 10, 131-141(1996) (Pubitemid 26056005)
104. E. M. Sloand, N. S. Young, P. Kumar, F. F. Weichold, T. Sato and J. P. Maciejewski: Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. Blood 89, 1357-1363(1997) (Pubitemid 27080000)
105. T. W. McCloskey, N. Oyaizu, M. Kaplan and S. Pahwa: Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry 22, 111-114(1995)
106. A. Algeciras, D. H. Dockrell, D. H. Lynch and C. V. Paya: CD4 regulates susceptibility to Fas ligand-and tumor necrosis factor-mediated apoptosis. J Exp Med 187, 711-720. (1998) (Pubitemid 28115187)
107. A. D. Badley, D. Dockrell, M. Simpson, R. Schut, D. H. Lynch, P. Leibson and C. V. Paya: Macrophagedependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med 185, 55-64. (1997) (Pubitemid 27039440)
108. I. Jeremias, I. Herr, T. Boehler and K. M. Debatin: TRAIL/Apo-2-ligand- induced apoptosis in human T cells. Eur J Immunol 28, 143-152(1998) (Pubitemid 28048285)
109. G. Herbein, U. Mahlknecht, F. Batliwalla, P. Gregersen, T. Pappas, J. Butler, W. A. O'Brien and E. Verdin: Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 395, 189-194. (1998) (Pubitemid 28425660)
110. L. M. de Oliveira Pinto, S. Garcia, H. Lecoeur, C. Rapp and M. L. Gougeon: Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1) - and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3. Blood 99, 1666-1675. (2002) (Pubitemid 34533040)
111. D. Arnoult, F. Petit, J. D. Lelievre, D. Lecossier, A. J. Hance, V. Monceaux, R. Ho Tsong Fang, B. Hurtrel, J. C. Ameisen and J. Estaquier: Caspase-dependent and - independent T cell death pathways in pathogenic Simian Immunodeficiency Virus infection. Relationship with disease evolution. Cell Death Differ in Press, (2003)
112. D. Mitra, M. Steiner, D. H. Lynch, L. Staiano-Coico and J. Laurence: HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: association with Fasmediated apoptosis and modulation by aurintricarboxylic acid. Immunology 87, 581-585(1996) (Pubitemid 26116467)
113. D. H. Dockrell, A. D. Badley, J. S. Villacian, C. J. Heppelmann, A. Algeciras, S. Ziesmer, H. Yagita, D. H. Lynch, P. C. Roche, P. J. Leibson and C. V. Paya: The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. J Clin Invest 101, 2394-2405(1998) (Pubitemid 28270434)
114. J. D. Lelievre, F. Mammano, D. Arnoult, F. Petit, A. Grodet, J. Estaquier and J. C. Ameisen: A novel mechanism for HIV1-mediated bystander CD4+ T-cell death: neighboring dying cells drive the capacity of HIV1 to kill noncycling primary CD4+ T cells. Cell Death Differ 11, 1017-1027(2004) (Pubitemid 39232361)
115. M. O. Hengartner: The biochemistry of apoptosis. Nature 407, 770-776. (2000)
116. A. D. Badley, K. Parato, D. W. Cameron, S. Kravcik, B. N. Phenix, D. Ashby, A. Kumar, D. H. Lynch, J. Tschopp and J. B. Angel: Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ 6, 420-432(1999) (Pubitemid 29245956)
117. S. R. Vlahakis, A. Algeciras-Schimnich, G. Bou, C. J. Heppelmann, A. Villasis-Keever, R. C. Collman and C. V. Paya: Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. J Clin Invest 107, 207-215. (2001) (Pubitemid 32096837)
118. Z. Q. Wang, A. Dudhane, T. Orlikowsky, K. Clarke, X. Li, Z. Darzynkiewicz and M. K. Hoffmann: CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur J Immunol 24, 1549-1552(1994) (Pubitemid 24203759)
119. J. Desbarats, J. H. Freed, P. A. Campbell and M. K. Newell: Fas (CD95) expression and death-mediating function are induced by CD4 cross-linking on CD4+ T cells. Proc Natl Acad Sci U S A 93, 11014-11018. (1996) (Pubitemid 26333109)
120. N. Oyaizu, T. W. McCloskey, S. Than, R. Hu, V. S. Kalyanaraman and S. Pahwa: Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion. Blood 84, 2622-2631(1994) (Pubitemid 24317395)
121. M. Tateyama, N. Oyaizu, T. W. McCloskey, S. Than and S. Pahwa: CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway. Blood 96, 195-202(2000) (Pubitemid 30456471)
122. N. K. Banda, J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R. P. Sekaly and T. H. Finkel: Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176, 1099-1106(1992)
123. H. Ohnimus, M. Heinkelein and C. Jassoy: Apoptotic cell death upon contact of CD4+ T lymphocytes with HIV glycoprotein-expressing cells is mediated by caspases but bypasses CD95 (Fas/Apo-1) and TNF receptor 1. J Immunol 159, 5246-5252(1997) (Pubitemid 127470050)
124. F. Luciani, P. Matarrese, A. M. Giammarioli, L. Lugini, F. Lozupone, C. Federici, E. Iessi, W. Malorni and S. Fais: CD95/phosphorylated ezrin association underlies HIV-1 GP120/IL-2-induced susceptibility to CD95 (APO-1/Fas)-mediated apoptosis of human resting CD4 (+) T lymphocytes. Cell Death Differ 11, 574-582(2004) (Pubitemid 38660142)
125. C. Berndt, B. Mopps, S. Angermuller, P. Gierschik and P. H. Krammer: CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4 (+) T cells. Proc Natl Acad Sci U S A 95, 12556-12561. (1998)
126. M. Biard-Piechaczyk, V. Robert-Hebmann, V. Richard, J. Roland, R. A. Hipskind and C. Devaux: Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membraneassociated human immunodeficiency virus type 1 envelope glycoprotein (gp120). Virology 268, 329-344(2000) (Pubitemid 30159982)
127. J. Blanco, E. Jacotot, C. Cabrera, A. Cardona, B. Clotet, E. De Clercq and J. A. Este: The implication of the chemokine receptor CXCR4 in HIV-1 envelope proteininduced apoptosis is independent of the G protein-mediated signalling. Aids 13, 909-917(1999) (Pubitemid 29240185)
128. J. Hesselgesser, D. Taub, P. Baskar, M. Greenberg, J. Hoxie, D. L. Kolson and R. Horuk: Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol 8, 595-598. (1998) (Pubitemid 28222895)
129. F. Petit, J. Corbeil, J. D. Lelievre, L. M. Parseval, G. Pinon, D. R. Green, J. C. Ameisen and J. Estaquier: Role of CD95-activated caspase-1 processing of IL-1beta in TCR-mediated proliferation of HIV-infected CD4 (+) T cells. Eur J Immunol 31, 3513-3524. (2001) (Pubitemid 34030964)
130. J. Estaquier, J. D. Lelievre, F. Petit, T. Brunner, L. Moutouh-De Parseval, D. D. Richman, J. C. Ameisen and J. Corbeil: Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4 (+) T-cell death. J Virol 76, 5966-5973(2002) (Pubitemid 34556291)
131. G. H. Holm and D. Gabuzda: Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions. J Virol 79, 6299-6311(2005) (Pubitemid 40617234)
132. M. T. Esser, J. W. Bess, Jr., K. Suryanarayana, E. Chertova, D. Marti, M. Carrington, L. O. Arthur and J. D. Lifson: Partial activation and induction of apoptosis in CD4 (+) and CD8 (+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. J Virol 75, 1152-1164(2001) (Pubitemid 32094674)
133. E. A. Berger, P. M. Murphy and J. M. Farber: Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17, 657-700(1999) (Pubitemid 29241137)
134. R. D. Berkowitz, S. Alexander, C. Bare, V. Linquist-Stepps, M. Bogan, M. E. Moreno, L. Gibson, E. D. Wieder, J. Kosek, C. A. Stoddart and J. M. McCune: CCR5-and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. J Virol 72, 10108-10117. (1998) (Pubitemid 28520881)
135. J. D. Lelievre, F. Petit, L. Perrin, F. Mammano, D. Arnoult, J. C. Ameisen, J. Corbeil, A. Gervaix and J. Estaquier: The density of coreceptors at the surface of CD4+ T cells contributes to the extent of human immunodeficiency virus type 1 viral replication-mediated T cell death. AIDS Res Hum Retroviruses 20, 1230-1243(2004) (Pubitemid 39557873)
136. J. D. Lelievre, F. Petit, D. Arnoult, J. C. Ameisen and J. Estaquier: Interleukin 7 increases human immunodeficiency virus type 1 LAI-mediated Fas-induced T-cell death. J Virol 79, 3195-3199(2005) (Pubitemid 40270600)
137. S. A. Trushin, A. Algeciras-Schimnich, S. R. Vlahakis, G. D. Bren, S. Warren, D. J. Schnepple and A. D. Badley: Glycoprotein 120 binding to CXCR4 causes p38-dependent primary T cell death that is facilitated by, but does not require cell-associated CD4. J Immunol 178, 4846-4853(2007) (Pubitemid 46595266)
138. R. S. Veazey, P. J. Klasse, T. J. Ketas, J. D. Reeves, M. Piatak, Jr., K. Kunstman, S. E. Kuhmann, P. A. Marx, J. D. Lifson, J. Dufour, M. Mefford, I. Pandrea, S. M. Wolinsky, R. W. Doms, J. A. De Martino, S. J. Siciliano, K. Lyons, M. S. Springer and J. P. Moore: Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection. J Exp Med 198, 1551-1562(2003) (Pubitemid 37467169)
139. J. P. Herbeuval, A. Boasso, J. C. Grivel, A. W. Hardy, S. A. Anderson, M. J. Dolan, C. Chougnet, J. D. Lifson and G. M. Shearer: TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood 105, 2458-2464(2005) (Pubitemid 40387046)
140. J. P. Herbeuval, J. C. Grivel, A. Boasso, A. W. Hardy, C. Chougnet, M. J. Dolan, H. Yagita, J. D. Lifson and G. M. Shearer: CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. Blood 106, 3524-3531(2005) (Pubitemid 41609189)
141. Y. Adachi, N. Oyaizu, S. Than, T. W. McCloskey and S. Pahwa: IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2. J Immunol 157, 4184-4193(1996) (Pubitemid 126449333)
142. J. Chehimi, J. D. Marshall, O. Salvucci, I. Frank, S. Chehimi, S. Kawecki, D. Bacheller, S. Rifat and S. Chouaib: IL-15 enhances immune functions during HIV infection. J Immunol 158, 5978-5987(1997) (Pubitemid 127484007)
143. Y. M. Mueller, S. C. De Rosa, J. A. Hutton, J. Witek, M. Roederer, J. D. Altman and P. D. Katsikis: Increased CD95/Fas-induced apoptosis of HIV-specific CD8 (+) T cells. Immunity 15, 871-882(2001) (Pubitemid 34075369)
144. Y. M. Mueller, V. Makar, P. M. Bojczuk, J. Witek and P. D. Katsikis: IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4 (+) and CD8 (+) effector-memory T cells. Int Immunol 15, 49-58(2003) (Pubitemid 36163768)
145. T. J. Fry, E. Connick, J. Falloon, M. M. Lederman, D. J. Liewehr, J. Spritzler, S. M. Steinberg, L. V. Wood, R. Yarchoan, J. Zuckerman, A. Landay and C. L. Mackall: A potential role for interleukin-7 in T-cell homeostasis. Blood 97, 2983-2990. (2001)
146. C. L. Mackall, T. J. Fry, C. Bare, P. Morgan, A. Galbraith and R. E. Gress: IL-7 increases both thymicdependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97, 1491-1497. (2001) (Pubitemid 32183777)
147. A. T. Vella, S. Dow, T. A. Potter, J. Kappler and P. Marrack: Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci U S A 95, 3810-3815. (1998) (Pubitemid 28173211)
148. A. Llano, J. Barretina, A. Gutierrez, J. Blanco, C. Cabrera, B. Clotet and J. A. Este: Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J Virol 75, 10319-10325. (2001) (Pubitemid 32948062)
149. A. Muthukumar, A. Wozniakowsli, M. C. Gauduin, M. Palardini, H. McClure, R. P. Johnson, G. Silvestri and D. L. Sodora: Elevated interleukin-7 levels not sufficient to maintain T-cell homeostasis during simian immunodeficiency virus-induced disease progression. Blood 103, 973-979. (2004) (Pubitemid 38129559)
150. L. A. Napolitano, R. M. Grant, S. G. Deeks, D. Schmidt, S. C. De Rosa, L. A. Herzenberg, B. G. Herndier, J. Andersson and J. M. McCune: Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 7, 73-79. (2001) (Pubitemid 32095644)
151. M. D. Smithgall, J. G. Wong, K. E. Critchett and O. K. Haffar: IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. J Immunol 156, 2324-2330. (1996) (Pubitemid 26087464)
152. C. M. Steffens, E. Z. Managlia, A. Landay and Al-Harthi L.: Interleukin-7-treated naive T cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1. Blood 99, 3310-3318(2002) (Pubitemid 34525312)
153. C. Fluur, A. De Milito, T. J. Fry, N. Vivar, L. Eidsmo, A. Atlas, C. Federici, P. Matarrese, M. Logozzi, E. Rajnavolgyi, C. L. Mackall, S. Fais, F. Chiodi and B. Rethi: Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection. J Immunol 178, 5340-5350(2007) (Pubitemid 46595320)
154. G. Nunnari, Y. Xu, E. A. Acheampong, J. Fang, R. Daniel, C. Zhang, H. Zhang, M. Mukhtar and R. J. Pomerantz: Exogenous IL-7 induces Fas-mediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection. J Neurovirol 11, 319-328(2005) (Pubitemid 41614511)
155. Y. Ishida, Y. Agata, K. Shibahara and T. Honjo: Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. Embo J 11, 3887-3895(1992)
156. L. Trautmann, L. Janbazian, N. Chomont, E. A. Said, G. Wang, S. Gimmig, B. Bessette, M. R. Boulassel, E. Delwart, H. Sepulveda, R. S. Balderas, J. P. Routy, E. K. Haddad and R. P. Sekaly: Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction. Nat Med (2006)
157. C. Petrovas, J. P. Casazza, J. M. Brenchley, D. A. Price, E. Gostick, W. C. Adams, M. L. Precopio, T. Schacker, M. Roederer, D. C. Douek and R. A. Koup: PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med (2006)
158. C. L. Day, D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. Depierres, Z. Mncube, J. Duraiswamy, B. Zhu, Q. Eichbaum, M. Altfeld, E. J. Wherry, H. M. Coovadia, P. J. Goulder, P. Klenerman, R. Ahmed, G. J. Freeman and B. D. Walker: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature (2006)
159. M. C. Cumont, V. Monceaux, L. Viollet, S. Lay, R. Parker, B. Hurtrel and J. Estaquier: TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus. Cell Death Differ 14, 1747-1758(2007) (Pubitemid 47423642)
160. R. V. Parry, J. M. Chemnitz, K. A. Frauwirth, A. R. Lanfranco, I. Braunstein, S. V. Kobayashi, P. S. Linsley, C. B. Thompson and J. L. Riley: CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 25, 9543-9553(2005) (Pubitemid 41507854)
161. D. E. Kaufmann, D. G. Kavanagh, F. Pereyra, J. J. Zaunders, E. W. Mackey, T. Miura, S. Palmer, M. Brockman, A. Rathod, A. Piechocka-Trocha, B. Baker, B. Zhu, S. Le Gall, M. T. Waring, R. Ahern, K. Moss, A. D. Kelleher, J. M. Coffin, G. J. Freeman, E. S. Rosenberg and B. D. Walker: Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 8, 1246-1254(2007) (Pubitemid 350011764)
162. M. Castedo, A. Macho, N. Zamzami, T. Hirsch, P. Marchetti, J. Uriel and G. Kroemer: Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur J Immunol 25, 3277-3284(1995) (Pubitemid 26004929)
163. S. A. Susin, H. K. Lorenzo, N. Zamzami, I. Marzo, B. E. Snow, G. M. Brothers, J. Mangion, E. Jacotot, P. Costantini, M. Loeffler, N. Larochette, D. R. Goodlett, R. Aebersold, D. P. Siderovski, J. M. Penninger and G. Kroemer: Molecular characterization of mitochondrial apoptosis-inducing factor [see comments]. Nature 397, 441-446(1999)
164. D. Arnoult, P. Parone, J. C. Martinou, B. Antonsson, J. Estaquier and J. C. Ameisen: Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J Cell Biol 159, 923-929(2002) (Pubitemid 36055747)
165. M. C. Wei, W. X. Zong, E. H. Cheng, T. Lindsten, V. Panoutsakopoulou, A. J. Ross, K. A. Roth, G. R. MacGregor, C. B. Thompson and S. J. Korsmeyer: Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730. (2001) (Pubitemid 32385543)
166. J. E. Ricci, C. Munoz-Pinedo, P. Fitzgerald, B. Bailly-Maitre, G. A. Perkins, N. Yadava, I. E. Scheffler, M. H. Ellisman and D. R. Green: Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117, 773-786(2004) (Pubitemid 38748893)
167. A. Cossarizza, C. Mussini, N. Mongiardo, V. Borghi, A. Sabbatini, B. De Rienzo and C. Franceschi: Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome. Aids 11, 19-26(1997) (Pubitemid 27023208)
168. J. L. Perfettini, M. Castedo, R. Nardacci, F. Ciccosanti, P. Boya, T. Roumier, N. Larochette, M. Piacentini and G. Kroemer: Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J Exp Med 201, 279-289(2005) (Pubitemid 40189437)
169. D. Arnoult, M. Karbowski and R. J. Youle: Caspase inhibition prevents the mitochondrial release of apoptosisinducing factor. Cell Death Differ 10, 845-849(2003) (Pubitemid 36850245)
170. Y. M. Mueller, P. M. Bojczuk, E. S. Halstead, A. H. Kim, J. Witek, J. D. Altman and P. D. Katsikis: IL-15 enhances survival and function of HIV-specific CD8+ T cells. Blood 101, 1024-1029(2003) (Pubitemid 36139375)
171. P. Bouillet, S. Cory, L. C. Zhang, A. Strasser and J. M. Adams: Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell 1, 645-653(2001) (Pubitemid 33586117)
172. P. Bouillet, D. Metcalf, D. C. Huang, D. M. Tarlinton, T. W. Kay, F. Kontgen, J. M. Adams and A. Strasser: Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735-1738(1999) (Pubitemid 129515880)
173. P. D. Hughes, G. T. Belz, K. A. Fortner, R. C. Budd, A. Strasser and P. Bouillet: Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 28, 197-205(2008) (Pubitemid 351215234)
174. J. Hutcheson, J. C. Scatizzi, A. M. Siddiqui, G. K. Haines, 3rd, T. Wu, Q. Z. Li, L. S. Davis, C. Mohan and H. Perlman: Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28, 206-217(2008) (Pubitemid 351215233)
175. A. E. Weant, R. D. Michalek, I. U. Khan, B. C. Holbrook, M. C. Willingham and J. M. Grayson: Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity 28, 218-230(2008) (Pubitemid 351215232)
176. J. van Grevenynghe, F. A. Procopio, Z. He, N. Chomont, C. Riou, Y. Zhang, S. Gimmig, G. Boucher, P. Wilkinson, Y. Shi, B. Yassine-Diab, E. A. Said, L. Trautmann, M. El Far, R. S. Balderas, M. R. Boulassel, J. P. Routy, E. K. Haddad and R. P. Sekaly: Transcription factor FOXO3a controls the persistence of memory CD4 (+) T cells during HIV infection. Nat Med 14, 266-274(2008) (Pubitemid 351347916)
177. B. Hurtrel, F. Petit, D. Arnoult, M. Muller-Trutwin, G. Silvestri and J. Estaquier: Apoptosis in SIV infection. Cell Death Differ 12 Suppl 1, 979-990(2005) (Pubitemid 41030611)